News
A 14-month randomized trial in older African American adults with obesity found that adopting a Mediterranean diet, with or ...
A new tool in understanding and improving nutrition for all now resides at the University of Alabama at Birmingham. The ...
Introduction Obesity treatment guidelines suggest moderate-intensity continuous training (MICT), but the patient’s compliance to this indication remains low. High-intensity interval training (HIIT) is ...
Research carried out on mice has revealed how a hormone released by the intestine acts on the brain and helps regulate the ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
Dr. Teresa LaMasters, who leads the American Society for Metabolic and Bariatric Surgery, said this research shows how useful ...
Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...
Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...
Once-weekly amycretin, a novel peptide activating GLP-1, amylin, and calcitonin receptors, produced rapid, substantial, and ...
Use of an investigational monoclonal antibody called bimagrumab added to semaglutide produced weight loss while preserving ...
Specifically, researchers found that eating four different diets (a low-fat, low-carb, Mediterranean or green Mediterranean ...
The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results